Find uplifting stories about heroes, innovations, and solutions
1553 results for "alzheimer's cure"
Scientists say someone alive today could become the first person ever cured of Alzheimer's disease. After decades of research, breakthrough treatments and revolutionary blood tests are bringing hope to millions of families touched by dementia.
Scientists say the first person to be cured of Alzheimer's disease may already be alive today. With over 190 trials underway and breakthrough treatments already approved, researchers call this a turning point in the fight against dementia.
Vanderbilt researchers developed two groundbreaking compounds that could finally reveal what causes Alzheimer's disease at a molecular level. These chemical tools offer scientists new ways to study a mysterious protein family linked to the disease affecting over seven million Americans.
Johns Hopkins scientists discovered that hydrogen sulfide, the gas that smells like rotten eggs, plays a crucial role in protecting memory and brain health. Mice lacking the protein that produces this gas developed Alzheimer's-like symptoms, opening a promising new path for treatment.
A self-made businessman who turned $3,500 into millions is now betting his energy on something bigger: curing diseases like cancer and Alzheimer's. Lou Weisbach's American Center for Cures brings business thinking to medical breakthroughs.
World-class Alzheimer's researchers are opening their doors to the public this Saturday for a free forum where anyone can get their questions answered. Over 100,000 San Diego County residents live with dementia, and this rare event connects them directly with scientists working on a cure.
A Florida grandfather completed an 18-month Alzheimer's treatment that cleared the amyloid plaques from his brain, bringing hope to families facing this devastating disease. While not a cure, the breakthrough therapy slowed disease progression and helped him return to fishing, traveling, and cherishing moments with his grandson.
For the first time in history, new drugs can slow Alzheimer's progression by years, not months. Scientists say better diagnosis and funding could turn these promising treatments into a genuine cure.
A Korean research institute is racing to develop the world's first true dementia treatment by 2035, with three promising drug candidates already in clinical trials. The team believes their unique approach could finally crack the code on Alzheimer's disease.
Four leading European research institutes have joined forces to speed up treatments for Alzheimer's, Parkinson's, and other brain diseases affecting millions. The CURE-ND Alliance brings together over 2,500 scientists working to transform how we understand and treat neurodegenerative diseases.
Health Canada has authorized Kisunla, a breakthrough treatment that slows early Alzheimer's progression by 22% and can be stopped once brain plaques clear. Over 770,000 Canadians living with Alzheimer's now have access to the first disease-modifying therapy that targets the root cause of memory loss.
Vanderbilt researchers developed two breakthrough compounds that let scientists study TAOK proteins for the first time, opening new paths to understanding and potentially treating Alzheimer's disease. More than seven million Americans with Alzheimer's now have new hope for future treatments.
Millions of families caring for loved ones with Alzheimer's just got meaningful help. The FDA has approved AXS-05, the first treatment specifically designed to ease agitation in Alzheimer's patients.
In Minnesota, where over 102,000 seniors live with Alzheimer's, RBC Wealth Management is partnering with the Alzheimer's Association to support families navigating one of life's hardest journeys. The collaboration provides resources, education, and hope to those touched by dementia.
The FDA just approved LEQEMBI IQLIK, the first Alzheimer's treatment patients can give themselves at home from day one. The weekly autoinjector takes just 15 seconds per dose and could transform how millions manage early Alzheimer's disease. #
A groundbreaking study of over 21,000 patient records reveals that women taking estrogen-only hormone therapy showed fewer signs of dementia and Alzheimer's disease. The research offers new hope for understanding why two-thirds of Alzheimer's patients are women.
A team of researchers across five countries just received $24 million to find a cure for hepatitis B, a virus that affects 300 million people worldwide. The five-year effort could finally bring hope to millions living with a disease that currently has no cure.
New research links blood sugar spikes after meals to Alzheimer's disease risk, offering hope that simple diet changes could protect brain health. Scientists found genetic predisposition to post-meal sugar spikes increased relative Alzheimer's risk by 69 percent.
New research confirms Maria Shriver's decades-old hunch: women represent two-thirds of Alzheimer's diagnoses, but scientists now say nearly half of all cases can be prevented. After her father's diagnosis, Shriver founded the Women's Alzheimer's Movement and is empowering people to take charge of their brain health early.
A new stem cell transplant developed at Johns Hopkins has cured sickle cell disease in 95% of patients, using half-matched donors like parents or siblings. The breakthrough means nearly every sickle cell patient can now access a cure that also preserves fertility.
Showing 20 of 1553